Patents by Inventor Hemin Feng

Hemin Feng has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method and composition for treating mental disorder and pain associated with nerve damage
    Patent number: 11285161
    Abstract: A method of treating a subject suffering from mental disorder including the step of administering an effective amount of a cholecystokinin-2 receptor antagonist or a pharmaceutical acceptable salt thereof to the subject. A method of treating a subject suffering from pain associated with nerve injury including the step of administering an effective amount of a cholecystokinin-2 receptor antagonist or a pharmaceutical acceptable salt thereof to the subject. A pharmaceutical composition including the cholecystokinin-2 receptor antagonist or a pharmaceutical acceptable salt thereof as active ingredient, one or more antidepressant compounds, and a pharmaceutically acceptable excipient.
    Type: Grant
    Filed: April 26, 2019
    Date of Patent: March 29, 2022
    Assignee: City University of Hong Kong
    Inventors: Jufang He, Xu Zhang, Hemin Feng, Ge Zhang, Shenghui Xu, Sarah Hau
  • METHOD AND COMPOSITION FOR TREATING MENTAL DISORDER AND PAIN ASSOCIATED WITH NERVE DAMAGE
    Publication number: 20200338089
    Abstract: A method of treating a subject suffering from mental disorder including the step of administering an effective amount of a cholecystokinin-2 receptor antagonist or a pharmaceutical acceptable salt thereof to the subject. A method of treating a subject suffering from pain associated with nerve injury including the step of administering an effective amount of a cholecystokinin-2 receptor antagonist or a pharmaceutical acceptable salt thereof to the subject. A pharmaceutical composition including the cholecystokinin-2 receptor antagonist or a pharmaceutical acceptable salt thereof as active ingredient, one or more antidepressant compounds, and a pharmaceutically acceptable excipient.
    Type: Application
    Filed: April 26, 2019
    Publication date: October 29, 2020
    Inventors: Jufang He, Xu Zhang, Hemin Feng, Ge Zhang, Shenghui Xu, Sarah Hau